Kymera Therapeutics, Inc. (KYMR) — SC 13D/A Filings
All SC 13D/A filings from Kymera Therapeutics, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Baker Bros. Advisors Amends Kymera Therapeutics Stake
— Aug 22, 2024 Risk: medium
Baker Bros. Advisors LP, through its group members Felix J. Baker and Julian C. Baker, has filed an amendment (Amendment No. 1) to its Schedule 13D concerning K -
BVF Partners Amends Kymera Therapeutics Stake, Signals Ownership Shift
— Jan 9, 2024
BVF Partners L.P., a significant shareholder in Kymera Therapeutics, Inc., filed an Amendment No. 4 to its Schedule 13D on January 9, 2024, indicating a change
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX